These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36081770)

  • 1. COVID-19 severity is associated with population-level gut microbiome variations.
    Lymberopoulos E; Gentili GI; Budhdeo S; Sharma N
    Front Cell Infect Microbiol; 2022; 12():963338. PubMed ID: 36081770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower gut abundance of
    Liu Y; Chan MTV; Chan FKL; Wu WKK; Ng SC; Zhang L
    Front Cell Infect Microbiol; 2023; 13():1249069. PubMed ID: 37743871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
    Yeoh YK; Zuo T; Lui GC; Zhang F; Liu Q; Li AY; Chung AC; Cheung CP; Tso EY; Fung KS; Chan V; Ling L; Joynt G; Hui DS; Chow KM; Ng SSS; Li TC; Ng RW; Yip TC; Wong GL; Chan FK; Wong CK; Chan PK; Ng SC
    Gut; 2021 Apr; 70(4):698-706. PubMed ID: 33431578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topological Data Analysis Highlights Novel Geographical Signatures of the Human Gut Microbiome.
    Lymberopoulos E; Gentili GI; Alomari M; Sharma N
    Front Artif Intell; 2021; 4():680564. PubMed ID: 34490420
    [No Abstract]   [Full Text] [Related]  

  • 6. Associations between Diet, the Gut Microbiome, and Short-Chain Fatty Acid Production among Older Caribbean Latino Adults.
    Maldonado-Contreras A; Noel SE; Ward DV; Velez M; Mangano KM
    J Acad Nutr Diet; 2020 Dec; 120(12):2047-2060.e6. PubMed ID: 32798072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection.
    Shenoy S
    Inflamm Res; 2022 Jan; 71(1):13-26. PubMed ID: 34738147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring
    Ladeira R; Tap J; Derrien M
    Microbiome Res Rep; 2023; 2(2):9. PubMed ID: 38047280
    [No Abstract]   [Full Text] [Related]  

  • 10. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.
    Reinold J; Farahpour F; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Hoffmann D; Buer J; Witzke O; Westendorf AM; Kehrmann J
    Front Cell Infect Microbiol; 2021; 11():747816. PubMed ID: 34869058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causal effects of the gut microbiome on COVID-19 susceptibility and severity: a two-sample Mendelian randomization study.
    Zhong MM; Xie JH; Feng Y; Zhang SH; Xia JN; Tan L; Chen NX; Su XL; Zhang Q; Feng YZ; Guo Y
    Front Immunol; 2023; 14():1173974. PubMed ID: 37720222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review.
    Farsi Y; Tahvildari A; Arbabi M; Vazife F; Sechi LA; Shahidi Bonjar AH; Jamshidi P; Nasiri MJ; Mirsaeidi M
    Front Cell Infect Microbiol; 2022; 12():804644. PubMed ID: 35310853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial Diversity: A Microbiome-Wide Analysis From Population Studies.
    Chen Z; Radjabzadeh D; Chen L; Kurilshikov A; Kavousi M; Ahmadizar F; Ikram MA; Uitterlinden AG; Zhernakova A; Fu J; Kraaij R; Voortman T
    JAMA Netw Open; 2021 Jul; 4(7):e2118811. PubMed ID: 34323983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis.
    Guo M; Wu G; Tan Y; Li Y; Jin X; Qi W; Guo X; Zhang C; Zhu Z; Zhao L
    mBio; 2023 Feb; 14(1):e0351922. PubMed ID: 36744910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19.
    Laterza L; Putignani L; Settanni CR; Petito V; Varca S; De Maio F; Macari G; Guarrasi V; Gremese E; Tolusso B; Wlderk G; Pirro MA; Fanali C; Scaldaferri F; Turchini L; Amatucci V; Sanguinetti M; Gasbarrini A
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust cross-cohort gut microbiome associations with COVID-19 severity.
    Li J; Ghosh TS; McCann R; Mallon P; Hill C; Draper L; Schult D; Fanning LJ; Shannon R; Sadlier C; Horgan M; O'Mahony L; O'Toole PW
    Gut Microbes; 2023; 15(1):2242615. PubMed ID: 37550964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis.
    Gupta VK; Cunningham KY; Hur B; Bakshi U; Huang H; Warrington KJ; Taneja V; Myasoedova E; Davis JM; Sung J
    Genome Med; 2021 Sep; 13(1):149. PubMed ID: 34517888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study.
    Kang DW; Adams JB; Gregory AC; Borody T; Chittick L; Fasano A; Khoruts A; Geis E; Maldonado J; McDonough-Means S; Pollard EL; Roux S; Sadowsky MJ; Lipson KS; Sullivan MB; Caporaso JG; Krajmalnik-Brown R
    Microbiome; 2017 Jan; 5(1):10. PubMed ID: 28122648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic support of the causal association between gut microbiome and COVID-19: a bidirectional Mendelian randomization study.
    Li Z; Zhu G; Lei X; Tang L; Kong G; Shen M; Zhang L; Song L
    Front Immunol; 2023; 14():1217615. PubMed ID: 37483615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome diversity, variability, and latent community types compared with shifts in body weight during the freshman year of college in dormitory-housed adolescents.
    Mohr AE; Ahern MM; Sears DD; Bruening M; Whisner CM
    Gut Microbes; 2023 Dec; 15(2):2250482. PubMed ID: 37642346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.